Literature DB >> 6749335

Determination of erythrocyte superoxide dismutase, catalase, glucose-6-phosphate dehydrogenase, reduced glutathione and malonyldialdehyde in uremia.

D P Chauhan, P H Gupta, M R Nampoothiri, P C Singhal, K S Chugh, C R Nair.   

Abstract

Erythrocyte superoxide dismutase (SOD: EC 1.15.1.1), catalase (EC 1.15.1.6), glucose-6-phosphate dehydrogenase (G-6-PD: EC 1.1.1.49), reduced glutathione (GSH) and malonyldialdehyde (MDA) were studied in 27 patients with chronic and 11 patients with acute renal failure. A comparison with 15 age- and sex-matched healthy subjects showed that patients with both acute and chronic renal failure had significantly low G-6-PD (p less than 0.05) values whereas SOD, catalase and MDA showed significantly elevated levels (p less than 0.05). After adequate dialysis or renal transplantation the SOD, G-6-PD, catalase and MDA values returned to normal. The findings suggest that the erythrocyte SOD, catalase, and G-6-PD can undergo an adaptive alteration which however appears reversible.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6749335     DOI: 10.1016/0009-8981(82)90124-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  Glutathione and its associated enzymes in peripheral blood cells in different stages of chronic renal insufficiency.

Authors:  J Mimic-Oka; T Simic; L Djukanovic; J Stefanovski; Z Ramic
Journal:  Amino Acids       Date:  1992-10       Impact factor: 3.520

2.  Stiffening of connective tissue in elderly diabetic patients: relevance to diabetic nephropathy and oxidative stress.

Authors:  Y Aoki; K Yazaki; K Shirotori; Y Yanagisawa; H Oguchi; K Kiyosawa; S Furuta
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

3.  Early oxidative change in low density lipoproteins during progressive chronic renal failure.

Authors:  M Sasikala; C Subramanyam; B Sadasivudu
Journal:  Indian J Clin Biochem       Date:  1999-07

4.  The effect of treatment with high dose melphalan, cisplatin or carboplatin on levels of glutathione in plasma, erythrocytes, mononuclear cells and urine.

Authors:  L Hogarth; M English; L Price; R Wyllie; A D Pearson; A G Hall
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

5.  Albumin thiol oxidation and serum protein carbonyl formation are progressively enhanced with advancing stages of chronic kidney disease.

Authors:  Yukie Matsuyama; Hiroyuki Terawaki; Tomoyoshi Terada; Seiichi Era
Journal:  Clin Exp Nephrol       Date:  2009-04-11       Impact factor: 2.801

6.  Adequate hemodialysis improves anemia by enhancing glucose-6-phosphate dehydrogenase activity in patients with end-stage renal disease.

Authors:  Mahmoud Husni Ayesh Haj Yousef; Ahnaf Bataineh; Elham Elamin; Yousef Khader; Khaldoon Alawneh; Mohamad Rababah
Journal:  BMC Nephrol       Date:  2014-09-26       Impact factor: 2.388

7.  Effects of coenzyme Q10 on the antioxidant system in SD rats exposed to lipopolysaccharide-induced toxicity.

Authors:  Min-Hae Song; Ha-Na Kim; Yong Lim; In-Surk Jang
Journal:  Lab Anim Res       Date:  2017-03-27

8.  Effect of reuse of polysulfone membrane on oxidative stress during hemodialysis.

Authors:  P Ramakrishna; E Prabhakar Reddy; M M Suchitra; A R Bitla; P V Srinivasa Rao; V Sivakumar
Journal:  Indian J Nephrol       Date:  2012-05

Review 9.  Mitochondria: a new therapeutic target in chronic kidney disease.

Authors:  Simona Granata; Alessandra Dalla Gassa; Paola Tomei; Antonio Lupo; Gianluigi Zaza
Journal:  Nutr Metab (Lond)       Date:  2015-11-25       Impact factor: 4.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.